Studies on Pneumocystis jirovecii dihydropteroate synthase (DHPS) genotypes among non-HIV immunocompromised patients from developing countries are rare. In the present prospective investigation, 24 (11.8%) cases were found to be positive for Pneumocystis jirovecii out of 203 non-HIV patients with a clinical suspicion of Pneumocystis pneumonia (PCP). Dihydropteroate synthase (DHPS) genotype 1 (Thr55Pro57) was noted in 95.8% P. jirovecii isolates in the present study in contrast to only 4.1% of patients with DHPS genotype 4 (Thr55Ala Pro57Ser). © 2011 ISHAM.
CITATION STYLE
Tyagi, A. K., Mirdha, B. R., Luthra, K., Guleria, R., Mohan, A., Singh, U. B., … Sreenivas, V. (2011). Pneumocystis jirovecii dihydropteroate synthase (DHPS) genotypes in non-HIV-immunocompromised patients: A tertiary care reference health centre study. Medical Mycology, 49(2), 167–171. https://doi.org/10.3109/13693786.2010.505584
Mendeley helps you to discover research relevant for your work.